Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 956 clinical trials
Featured trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis

participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria at Week 10 will have the option to enter a

remission
tumor necrosis factor alpha
vedolizumab
corticosteroids
immunomodulators
  • 2136 views
  • 26 Apr, 2019
  • 1 location
Featured trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease

participants who are biologic-naive and biologic-experienced. Participants who complete the study, or do not meet protocol response or remission criteria at Week 10 will have the option to enter a

tumor necrosis factor
tumour necrosis
maintenance treatment
remission
ustekinumab
  • 2243 views
  • 08 May, 2018
  • 1 location
Featured trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Giant Cell Arteritis  

  • 82 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With Moderate to Severe Active Ulcerative Colitis Who Are Naïve to TNF Inhibitors

Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Maintenance of Remission) and Safety of Etrolizumab Compared With Placebo in Patients With

  • 60 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

  • 290 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Ulcerative Colitis

Ulcerative Colitis

  • 28 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Ulcerative Colitis

Ulcerative Colitis

  • 48 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Ulcerative Colitis

Ulcerative Colitis

  • 38 views
  • 25 Mar, 2021
  • 1 location
Featured trial
A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

A Double-Blind, Randomized, Multicenter Study of Higher Versus Standard Adalimumab Dosing Regimens for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

  • 90 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Active Crohn’s Disease

Active Crohn’s Disease

  • 132 views
  • 08 Nov, 2020
  • 1 location